CVS
February 7, 2024 - AI Summary
Undervalued by 41.7% based on the discounted cash flow analysis.
Market cap | $72.21 Billion |
---|---|
Enterprise Value | $123.26 Billion |
Dividend Yield | $2.5062 (4.36%) |
Earnings per Share | $5.7 |
Beta | 0.38 |
Outstanding Shares | 1,255,372,972 |
Avg 30 Day Volume | 15,646,107 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 9.86 |
---|---|
PEG | -20.59 |
Price to Sales | 0.2 |
Price to Book Ratio | 0.99 |
Enterprise Value to Revenue | 0.34 |
Enterprise Value to EBIT | 9.43 |
Enterprise Value to Net Income | 16 |
Total Debt to Enterprise | 0.52 |
Debt to Equity | 0.87 |
No data
No data